Experience in the Design and Production of Recombinant Oral Vaccine «Revax VZT»

Experience in the Design and Production of Recombinant Oral Vaccine «Revax VZT»

Objective of the work was the production of recombinant vaccine «RevaxVZT» in tablet dosage form against hepatitis B and pathogenic for humans orthopoxviruses for further clinical trials. Materials and methods. Recombinant strain b7.5S2-S of vaccinia virus carrying a DNA fragment of hepatitis B viru...

Full description

Bibliographic Details
Main Authors: A. I. Terent’ev, V. A. Zhukov, Ar. A. Sergeev, S. B. Pastushenko, S. V. Rоgоzhkina, S. V. Borisevich, V. A. Maksimov, Al. A. Sergeev, K. A. Titova, D. O. Galakhova
Format: Article
Language:Russian
Published: Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2019-10-01
Series:Проблемы особо опасных инфекций
Subjects:
recombinant strain of vaccinia virus
hepatitis в
orthopoxviruses pathogenic for humans
smallpox vaccine in tablets
technology
hardware-processing line
Online Access:https://journal.microbe.ru/jour/article/view/1180

Internet

https://journal.microbe.ru/jour/article/view/1180

Similar Items